Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Otsuka Pharmaceutical Co. Ltd.

Division of Otsuka Holdings Co. Ltd.
www.otsuka.co.jp/en/

Latest From Otsuka Pharmaceutical Co. Ltd.

Nurish By Nature Made Extends Pharmavite Into Personalized, Subscription VMS Market

Otsuka Pharmaceutical Co. subsidiary announces nurish by Nature Made featuring 30-day supplies of vitamin packets delivered to customers after they complete online assessments evaluating core nutrient needs based on age, diet, lifestyle, wellness and general health.

Dietary Supplements Launches

Court Says FibroGen’s UK Roxadustat Patents Are Invalid

A complex and weighty judgment from the High Court regarding a new class of anemia compounds tackles a range of thorny patent law issues including obviousness, insufficiency and indirect infringement.

United Kingdom Intellectual Property

Deal Watch: Novartis Partners With TScan To Develop T-Cell Receptor-Targeted Therapies

Novartis/TScan and Gilead/Kite/oNKo-innate partnerships seek to advance cancer cell therapy. J&J, Bayer among the latest pharmas to unveil partnerships to fight the novel coronavirus.

Deals Business Strategies

Interview: Arvelle Aims To Be Major Player In CNS

The Swiss biotech's focal-onset seizure therapy, which is licensed from South Korea's SK and is already approved in the US, could have potential in indications beyond epilepsy, Arvelle's CEO tells Scrip.

Neurology Business Strategies
See All

Company Information

UsernamePublicRestriction

Register